InvestorsHub Logo
Followers 224
Posts 31837
Boards Moderated 4
Alias Born 10/10/2005

Re: None

Sunday, 11/26/2023 4:44:55 PM

Sunday, November 26, 2023 4:44:55 PM

Post# of 1029
The Investment contemplates the issuance of up to 24,727,361 common shares of Versus to CECG representing approximately 51% of the Company’s issued and outstanding common shares of which 15,838,441 common shares (the “First Tranche) were issued to CECG on November 22, 2023 and a further 8,888,920 common shares (the “Second Tranche”) are expected to be issued to CECG next week.

Per the terms of the agreement, CECG purchased the First Tranche at a price of $0.1618 per share, representing a premium to the five-day average Nasdaq Official Closing Price of $0.1578 per share, for a total USD $2,562,659.76. The Second Tranche will be completed at the same price per share.

Successful Trading is the art of minimizing long term risk and maximizing capital allocation.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VS News